Compounds > phosphotyrosine
Page last updated: 2024-08-23

phosphotyrosine and Lymph Node Metastasis

phosphotyrosine has been researched along with Lymph Node Metastasis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freydin, B; Hooke, JA; Hyslop, T; Klimowicz, AC; Kovatich, AJ; Liu, C; Magliocco, AM; Nevalainen, MT; Peck, AR; Pequignot, E; Rimm, DL; Rosenberg, AL; Rui, H; Sauter, G; Shriver, CD; Stringer, GA; Tran, TH; Witkiewicz, AK; Yang, N1
Camp, RL; Dolled-Filhart, M; Kowalski, DP; Rimm, DL; Smith, BL1
Collins, B; Gooding, WE; Grandis, JR; Handler, PN; Seethala, RR; Siegfried, JM; Zhang, Q1
Franco, RS; Lower, EE; Martelo, OJ; Miller, MA1

Other Studies

4 other study(ies) available for phosphotyrosine and Lymph Node Metastasis

ArticleYear
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-20, Volume: 29, Issue:18

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Cohort Studies; Disease Progression; Disease-Free Survival; Drug Resistance, Neoplasm; Estrogen Receptor Modulators; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Phosphorylation; Phosphotyrosine; Prognosis; Protein Processing, Post-Translational; STAT5 Transcription Factor; Survival Analysis; Treatment Failure; Tumor Suppressor Proteins; Young Adult

2011
Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:2

    Topics: Acute-Phase Proteins; Biomarkers; Breast Neoplasms; Cell Nucleus; DNA-Binding Proteins; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Multivariate Analysis; Phosphorylation; Phosphotyrosine; Prognosis; Proportional Hazards Models; STAT3 Transcription Factor; Survival Analysis; Time Factors; Trans-Activators

2003
Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Mar-01, Volume: 14, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Immunoenzyme Techniques; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Phosphotyrosine; Receptors, Bombesin; Signal Transduction; STAT3 Transcription Factor; Transcriptional Activation; Transforming Growth Factor alpha

2008
Enzymatic and immunohistochemical evaluation of tyrosine phosphorylation in breast cancer specimens.
    Breast cancer research and treatment, 1993, Volume: 26, Issue:3

    Topics: Breast; Breast Neoplasms; Cell Membrane; Cytosol; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Paraffin Embedding; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Tyrosine

1993